Now showing items 1-1 of 1

    • Reversing resistance to targeted therapy. 

      Vidal, L; Attard, G; Kaye, S; De Bono, J (2004-11)
      The development of molecular targeted anticancer drugs is rapidly changing cancer therapeutics. However, drug resistance to these novel agents remains a real clinical concern. Reports now indicate that resistance to many ...